Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CYTOKINETICS, INCORPORATED

(CYTK)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/20/2021 09/21/2021 09/22/2021 09/23/2021 09/24/2021 Date
32.43(c) 32.87(c) 33.84(c) 33.61(c) 33.13 Last
728 765 481 270 1 223 257 830 821 544 598 Volume
-4.31% +1.36% +2.95% -0.68% -1.43% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 23,4 M - -
Net income 2021 -235 M - -
Net cash position 2021 469 M - -
P/E ratio 2021 -10,8x
Yield 2021 -
Sales 2022 51,0 M - -
Net income 2022 -266 M - -
Net cash position 2022 294 M - -
P/E ratio 2022 -10,4x
Yield 2022 -
Capitalization 2 767 M 2 767 M -
EV / Sales 2021 98,0x
EV / Sales 2022 48,4x
Nbr of Employees 184
Free-Float 94,6%
More Financials
Company
Cytokinetics Inc. is a late-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. It is focused on the discovery and development of small molecule therapeutics that modulate muscle function for the treatment of serious... 
Sector
Biotechnology & Medical Research
Calendar
09/27 | 03:20pmPresentation
More about the company
Ratings of Cytokinetics, Incorporated
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about CYTOKINETICS, INCORPORATED
09/23CYTOKINETICS INCORPORATED : to Host Analyst & Investor Day on October 7, 2021
AQ
09/20CYTOKINETICS INCORPORATED : Corporate Presentation September 2021
PU
09/17INSIDER SELL : Cytokinetics
MT
09/13CYTOKINETICS INC : Other Events (form 8-K)
AQ
09/12CYTOKINETICS INCORPORATED : Announces Results From REDWOOD-HCM and GALACTIC-HF Presented i..
AQ
09/12CYTOKINETICS INCORPORATED : Corporate Presentation September 2021
PU
09/08Cytokinetics to Participate in September Investor Conferences
GL
09/07CYTOKINETICS INCORPORATED : to Host Investor Call and Webcast to Discuss the Full Results ..
AQ
09/03INSIDER SELL : Cytokinetics
MT
09/01CYTOKINETICS INCORPORATED : Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(..
PU
09/01CYTOKINETICS INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/01Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
08/31Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF to Be Presented in Late..
GL
08/31Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF to Be Presented in Late..
CI
08/19CYTOKINETICS INC : Other Events (form 8-K)
AQ
More news
News in other languages on CYTOKINETICS, INCORPORATED

- No features available -

More news
Analyst Recommendations on CYTOKINETICS, INCORPORATED
More recommendations
Chart CYTOKINETICS, INCORPORATED
Duration : Period :
Cytokinetics, Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CYTOKINETICS, INCORPORATED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 33,61 $
Average target price 45,30 $
Spread / Average Target 34,8%
EPS Revisions
Managers and Directors
Robert I. Blum President, Chief Executive Officer & Director
Ching W. Jaw Chief Financial Officer & Senior Vice President
Leonard Patrick Gage Chairman
Andrew A. Wolff Senior VP-Clinical Research & Development
Fady Ibraham Malik Executive Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
CYTOKINETICS, INCORPORATED59.43%2 807
GILEAD SCIENCES, INC.22.19%89 886
BIONTECH SE309.08%85 255
WUXI APPTEC CO., LTD.34.39%68 592
REGENERON PHARMACEUTICALS32.25%67 216
VERTEX PHARMACEUTICALS-22.31%48 018